212 related articles for article (PubMed ID: 34642183)
1. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
Valencia JC; Erwin-Cohen RA; Clavijo PE; Allen C; Sanford ME; Day CP; Hess MM; Johnson M; Yin J; Fenimore JM; Bettencourt IA; Tsuneyama K; Romero ME; Klarmann KD; Jiang P; Bae HR; McVicar DW; Merlino G; Edmondson EF; Anandasabapathy N; Young HA
Cancer Res; 2021 Dec; 81(23):5977-5990. PubMed ID: 34642183
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
[TBL] [Abstract][Full Text] [Related]
3. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
4. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
5. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Wang L; Hu D; Xie B; Xie L
Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
[TBL] [Abstract][Full Text] [Related]
8. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():606024. PubMed ID: 33986739
[TBL] [Abstract][Full Text] [Related]
9. Decitabine suppresses MDSC-induced immunosuppression through dual functional mechanism and inhibits melanoma metastasis.
Zhang Z; Wang T; Fang G; Xiao X; Zhang Z; Zhao J
Med Oncol; 2024 May; 41(7):165. PubMed ID: 38819590
[TBL] [Abstract][Full Text] [Related]
10. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
11. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
Front Immunol; 2021; 12():661323. PubMed ID: 34531850
[TBL] [Abstract][Full Text] [Related]
12. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment.
Halaby MJ; Hezaveh K; Lamorte S; Ciudad MT; Kloetgen A; MacLeod BL; Guo M; Chakravarthy A; Medina TDS; Ugel S; Tsirigos A; Bronte V; Munn DH; Pugh TJ; De Carvalho DD; Butler MO; Ohashi PS; Brooks DG; McGaha TL
Sci Immunol; 2019 Dec; 4(42):. PubMed ID: 31836669
[TBL] [Abstract][Full Text] [Related]
13. CCR5
Blattner C; Fleming V; Weber R; Himmelhan B; Altevogt P; Gebhardt C; Schulze TJ; Razon H; Hawila E; Wildbaum G; Utikal J; Karin N; Umansky V
Cancer Res; 2018 Jan; 78(1):157-167. PubMed ID: 29089297
[TBL] [Abstract][Full Text] [Related]
14. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
[TBL] [Abstract][Full Text] [Related]
15. Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.
Zhang M; Wang L; Liu W; Wang T; De Sanctis F; Zhu L; Zhang G; Cheng J; Cao Q; Zhou J; Tagliabue A; Bronte V; Yan D; Wan X; Yu G
J Immunol Res; 2022; 2022():2253436. PubMed ID: 35785030
[TBL] [Abstract][Full Text] [Related]
16. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
[TBL] [Abstract][Full Text] [Related]
18. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.
Oh MH; Sun IH; Zhao L; Leone RD; Sun IM; Xu W; Collins SL; Tam AJ; Blosser RL; Patel CH; Englert JM; Arwood ML; Wen J; Chan-Li Y; Tenora L; Majer P; Rais R; Slusher BS; Horton MR; Powell JD
J Clin Invest; 2020 Jul; 130(7):3865-3884. PubMed ID: 32324593
[TBL] [Abstract][Full Text] [Related]
19. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.
Wu H; Zhen Y; Ma Z; Li H; Yu J; Xu ZG; Wang XY; Yi H; Yang YG
Sci Transl Med; 2016 Mar; 8(331):331ra40. PubMed ID: 27009269
[TBL] [Abstract][Full Text] [Related]
20. Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis.
Dong C; Dang D; Zhao X; Wang Y; Wang Z; Zhang C
Front Immunol; 2021; 12():713001. PubMed ID: 34733272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
